Physician

John David Kayal, M.D.

According to 2025 Medicare claims, John Kayal, M.D. (NPI: 1366409880) practices dermatology in the Marietta, GA market, with the plurality of this provider's patient population coming from Cobb, GA. This provider's primary affiliated billing organization is KAYAL DERMATOLOGY & SKIN CANCER SPECIALISTS (NPI: 1235358441) and primary practice location at 30060-1118.

Kayal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 629 traditional Medicare patients, billed 5,974 HCPCS/CPT codes, and received $1,236,197 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,424 prescription claims across 497 beneficiaries totaling $791,658 in drug costs, led by Otezla (Apremilast). Open Payments data shows 142 records totaling $6,403. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $312,802 to $1,236,197. Similarly, Part D prescription costs have moved sharply higher in recent years, from $318,708 to $791,658. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	496	3,525	$312,802
2016	492	3,131	$268,450
2017	547	2,937	$261,221
2018	537	3,092	$233,814
2019	524	2,853	$244,537
2020	473	2,626	$211,156
2021	507	3,022	$306,026
2022	545	4,195	$532,150
2023	628	5,478	$819,491
2024	629	5,974	$1,236,197

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	311	1,025	$318,708
2016	300	843	$214,949
2017	298	777	$190,476
2018	302	783	$203,971
2019	336	931	$390,588
2020	323	945	$481,244
2021	350	955	$658,893
2022	407	1,154	$852,654
2023	430	1,203	$1,133,257
2024	497	1,424	$791,658

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	379	484	$88
11102	Biopsy of related skin growth, first growth	147	190	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	256	464	$64
17000	Destruction of precancer skin growth, 1 growth	197	312	$43
88305	Pathology examination of tissue using a microscope, intermediate complexity	173	268	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	21	630	$105,213
Cosentyx Sensoready (2 Pens)	Secukinumab	13	366	$91,139
Rinvoq	Upadacitinib	11	390	$78,476
Dupixent Syringe	Dupilumab	11	308	$41,013
Opzelura	Ruxolitinib Phosphate	16	478	$40,091

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	139	$5,394	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	3	$1,009	Regeneron Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John David Kayal, M.D.?

Tedicare shows public-source Medicare data for John David Kayal, M.D. (NPI 1366409880), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John David Kayal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John David Kayal, M.D.?

John David Kayal, M.D. is linked to KAYAL DERMATOLOGY & SKIN CANCER SPECIALISTS (billing NPI 1235358441) in the available physician profile data.

Does John David Kayal, M.D. have Open Payments data?

John David Kayal, M.D. has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.